Jeremy D. Walston,Peter M. Abadir,Alka Jain,Neal Fedarko
申请号：
US16848877
公开号：
US20200264173A1
申请日:
2020.04.15
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention described herein provides methods for treating a disease or disorder associated with angiotensin receptor signaling in a patient exhibiting elevated levels of ATIR autoantibodies. The invention also provides methods of identifying a patient suffering from a disease or disorder associated with angiotensin receptor signaling that may benefit from treatment with an angiotensin receptor blocker. Patients with elevated levels of ATIR autoantibodies arc identified as candidates that particularly benefit from treatment with an angiotensin receptor blocker.
